Drawing for COSTAR

USPTO serial 90437898

COSTAR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CAYSIDO, REBECCA TOLENTINO
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COSTAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard Y. Kim

Richard Y. Kim Snell & Wilmer L.L.P.One East Washington Street, Suite 2700Phoenix, AZ 85004-2556United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biologic preparations used for the treatment of cancer, namely, white blood cell and lymphocyte growth and stimulatory factors in the nature of cell growth media for growing cells for medical and clinical use, none of the foregoing in the field of laboratory research; all of the aforesaid goods relating to the development and research of cell and gene therapy for the treatment of cancerACTIVE—
039Providing transportation services of patient tumor samples and biomedical services and methods, namely, the storage of the patient tumor samples for medical use for cell growth and stimulation and white blood cell and lymphocyte growth and stimulation; all of the aforesaid services relating to the development and research of cell and gene therapy for the treatment of cancerACTIVE—
044Providing a website featuring information in the field of the diagnosis and treatment of cancer and in the field of cell growth and stimulation and white blood cell and lymphocyte growth and stimulation for the diagnosis and treatment of cancer; providing medical services for treating patients with tumors; all of the aforesaid services relating to the development and research of cell and gene therapy for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 9, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 9, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 30, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 30, 2024EX2GSOU EXTENSION 2 GRANTED—
Jul 30, 2024EXT2SOU EXTENSION 2 FILED—
Jul 30, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 18, 2024EXT1SOU EXTENSION 1 FILED—
Jan 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 8, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 19, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 19, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 19, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 26, 2023TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jun 26, 2023OP.TOPPOSITION TERMINATED NO. 999999—
Jun 26, 2023OP.DOPPOSITION DISMISSED NO. 999999—
Feb 22, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 18, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 27, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 27, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 27, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 27, 2022ALIEASSIGNED TO LIE—
Aug 2, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 27, 2022GAUNNOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED—
Jul 27, 2022GAUDNOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED—
Jul 27, 2022NAUDREPORT UNRESPONSIVE AMENDMENT - COMPLETED—
Jun 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 20, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 20, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 6, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 6, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 6, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 13, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2021DOCKASSIGNED TO EXAMINER—
Mar 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 4, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance